AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
RETROSPECTIVE ANALYSIS OF HEMATOLOGICAL PARAMETERS AND TRANSFUSION REQUIREMENTS IN BREAST-CANCER PATIENTS RECEIVING NON-PLATINUM-BASED CHEMOTHERAPY
Authors: GUASTALLA JP
Citation: Jp. Guastalla, RETROSPECTIVE ANALYSIS OF HEMATOLOGICAL PARAMETERS AND TRANSFUSION REQUIREMENTS IN BREAST-CANCER PATIENTS RECEIVING NON-PLATINUM-BASED CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 80-80
CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/
Authors: HERON JF JOLY F KERBRAT P CHAUVERGNE J MAYER F WEBER B CHINETCHARROT P CROUET H GOUPIL A LESECH JM LEBRUNJEZEKOVA D NAMER M MARTIN C GUASTALLA JP LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
TOPOTECAN(T) FOLLOWED BY ETOPOSIDE (E) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A GINECO PHASE-II STUDY
Authors: GUASTALLA JP FERRERO JM BENBUNAN JL KANOUI A GAUTIER H VINCENT P DARSE T CASTERA D JACQUIN JP CRETIN J BOUTANLAROZE A BICHOFFE A GOUTTEBEL MC PUJADELAURAINE E
Citation: Jp. Guastalla et al., TOPOTECAN(T) FOLLOWED BY ETOPOSIDE (E) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A GINECO PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 320-320
TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA)
Authors: VINCENT P GUASTALLA JP PIEDBOIS P WEBER B GANEM G CURE H TRILLETLENOIR V GOUPIL A MIGNOT L PUJADELAURAINE E
Citation: P. Vincent et al., TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA), Annals of oncology, 9, 1998, pp. 323-323
PHASE-III STUDY - TAXOTERE(R) (TXT) VERSUS 5-FLUOROURACIL PLUS NAVELBINE (FUN) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) AS 2NDLINE CHEMOTHERAPY (CT) (PRELIMINARY-RESULTS)
Authors: MONNIER A BONNETERRE J ROCHE H FARGEOT P NAMER M GUASTALLA JP RIOS M SERIN D CULINE S TUBIANA M EYMARD JC ASSADOURIAN S
Citation: A. Monnier et al., PHASE-III STUDY - TAXOTERE(R) (TXT) VERSUS 5-FLUOROURACIL PLUS NAVELBINE (FUN) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) AS 2NDLINE CHEMOTHERAPY (CT) (PRELIMINARY-RESULTS), Annals of oncology, 9, 1998, pp. 580-580
EFFICACY AND SAFETY OF THE PACLITAXEL AND CARBOPLATIN COMBINATION IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER GINECO ATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS) PHASE-II STUDY
Authors: GUASTALLA JP PUJADELAURAINE E WEBER B CURE H ORFEUVRE H MOUSSEAU M VINCENT P DIERAS V TUBIANAMATHIEU N JACQUIN JP MIGNOT L LEDUC B VIENS P PARISO D
Citation: Jp. Guastalla et al., EFFICACY AND SAFETY OF THE PACLITAXEL AND CARBOPLATIN COMBINATION IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER GINECO ATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS) PHASE-II STUDY, Annals of oncology, 9(1), 1998, pp. 37-43
PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF S9788, A NEW MULTIDRUG-RESISTANCE REVERSAL AGENT GIVEN ALONE AND IN COMBINATION WITH DOXORUBICIN TO PATIENTS WITH ADVANCED SOLID TUMORS
Authors: TRANCHAND B CATIMEL G LUCAS C SARKANY M BASTIAN G EVENE E GUASTALLA JP NEGRIER S REBATTU P DUMORTIER A FOY M GROSSIN F MAZIER B FROUDARAKIS M BARBET N CLAVEL M ARDIET C
Citation: B. Tranchand et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF S9788, A NEW MULTIDRUG-RESISTANCE REVERSAL AGENT GIVEN ALONE AND IN COMBINATION WITH DOXORUBICIN TO PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 281-291
PHASE-II TRIAL OF NAVELBINE AND FLUOROURACIL AS 2ND-LINE CHEMOTHERAPYIN METASTATIC BREAST-CARCINOMA
Authors: FROUDARAKIS ME CATIMEL G GUASTALLA JP REBATTU P CLAVEL M
Citation: Me. Froudarakis et al., PHASE-II TRIAL OF NAVELBINE AND FLUOROURACIL AS 2ND-LINE CHEMOTHERAPYIN METASTATIC BREAST-CARCINOMA, Oncology, 55(1), 1998, pp. 87-88
VINORELBINE AND CISPLATIN (CIVIC REGIMEN) FOR THE TREATMENT OF METASTATIC BREAST-CARCINOMA AFTER FAILURE OF ANTHRACYCLINE-CONTAINING AND ORPACLITAXEL-CONTAINING REGIMENS/
Authors: RAYCOQUARD I BIRON P BACHELOT T GUASTALLA JP CATIMEL G MERROUCHE Y DROZ JP CHAUVIN F BLAY JY
Citation: I. Raycoquard et al., VINORELBINE AND CISPLATIN (CIVIC REGIMEN) FOR THE TREATMENT OF METASTATIC BREAST-CARCINOMA AFTER FAILURE OF ANTHRACYCLINE-CONTAINING AND ORPACLITAXEL-CONTAINING REGIMENS/, Cancer, 82(1), 1998, pp. 134-140
A RISK MODEL FOR THROMBOCYTOPENIA REQUIRING PLATELET TRANSFUSION AFTER CYTOTOXIC CHEMOTHERAPY
Authors: BLAY JY LACESNE A MERMET C MAUGARD C RAVAUD A CHEVREAU C SEBBAN C GUASTALLA JP BIRON P RAYCOQUARD I
Citation: Jy. Blay et al., A RISK MODEL FOR THROMBOCYTOPENIA REQUIRING PLATELET TRANSFUSION AFTER CYTOTOXIC CHEMOTHERAPY, Blood, 92(2), 1998, pp. 405-410
CURRENT CONCEPTS IN THE MANAGEMENT OF OVARIAN-CANCER - PROCEEDINGS OFA SATELLITE SYMPOSIUM OF THE 1ST EUROPEAN SYMPOSIUM OF EPITHELIAL OVARIAN-CANCER JUNE 14, 1996 - INTRODUCTION
Authors: GUASTALLA JP
Citation: Jp. Guastalla, CURRENT CONCEPTS IN THE MANAGEMENT OF OVARIAN-CANCER - PROCEEDINGS OFA SATELLITE SYMPOSIUM OF THE 1ST EUROPEAN SYMPOSIUM OF EPITHELIAL OVARIAN-CANCER JUNE 14, 1996 - INTRODUCTION, International journal of gynecological cancer, 7, 1997, pp. 1-3
ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS
Authors: FUMOLEAU P CHAUVIN F NAMER M BUGAT R TUBIANAHULIN M GUASTALLA JP DELOZIER T KERBRAT P DEVAUX Y FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
EFFICACY AND SAFETY OF THE COMBINATION PACLITAXEL CARBOPLATIN IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER FRENCH GATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS PHASE-II STUDY/
Authors: PUJADELAURAINE E GUASTALLA JP WEBER B CURE H ORFEUVRE H MOUSSEAU M VINCENT P DIERAS V TUBIANAMATHIEU N JACQUIN JP MIGNOT L LEDUC B PARAISO D VIENS P
Citation: E. Pujadelauraine et al., EFFICACY AND SAFETY OF THE COMBINATION PACLITAXEL CARBOPLATIN IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER FRENCH GATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS PHASE-II STUDY/, Seminars in oncology, 24(5), 1997, pp. 30-35
PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/
Authors: CATIMEL G SPIELMANN M DIERAS V TUBIANAHULIN M BONNETERRE J POUILLART P KAYITALIRE L GUASTALLA JP GRAFFAND N GARET F DUMORTIER A PELLAECOSSET B
Citation: G. Catimel et al., PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/, Seminars in oncology, 24(1), 1997, pp. 8-12
SALVAGE LIVER SURGERY OF A CHEMOREFRACTORY OVARIAN CHORIOCARCINOMA
Authors: RIVOIRE M TREILLEUX I KAEMMERLEN P BARBET N GUASTALLA JP DROZ JP
Citation: M. Rivoire et al., SALVAGE LIVER SURGERY OF A CHEMOREFRACTORY OVARIAN CHORIOCARCINOMA, Gynecologic oncology, 65(1), 1997, pp. 185-187
PHASE-I STUDY OF GEMCITABINE USING A ONCE EVERY 2 WEEKS SCHEDULE
Authors: VERMORKEN JB GUASTALLA JP HATTY SR SEITZ DE TANIS B MCDANIELS C CLAVEL MD
Citation: Jb. Vermorken et al., PHASE-I STUDY OF GEMCITABINE USING A ONCE EVERY 2 WEEKS SCHEDULE, British Journal of Cancer, 76(11), 1997, pp. 1489-1493
INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY
Authors: PUJADELAURAINE E GUASTALLA JP COLOMBO N DEVILLIER P FRANCOIS E FUMOLEAU P MONNIER A NOOY M MIGNOT L BUGAT R MARQUES C MOUSSEAU M NETTER G MALOISEL F LARBAOUI S BRANDELY M
Citation: E. Pujadelauraine et al., INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Journal of clinical oncology, 14(2), 1996, pp. 343-350
TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY
Authors: CREEMERS GJ BOLIS G GORE M SCARFONE G LACAVE AJ GUASTALLA JP DESPAX R FAVALLI G KREINBERG R VANBELLE S HUDSON I VERWEIJ J HUININK WWT
Citation: Gj. Creemers et al., TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY, Journal of clinical oncology, 14(12), 1996, pp. 3056-3061
CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY
Authors: LHOMME C KERBRAT P LEJEUNE C GUASTALLA JP FUMOLEAU P GOUPIL A HERON JF CASSIN MA PRUVOT I SOARES JA CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY
Authors: CATIMEL G SPIELMANN M DIERAS V KAYITALIRE L POUILLART P GUASTALLA JP SOLERMICHEL P GRAFFAND N GARET F DUMORTIER A PELLAECOSSET B CHAZARD M
Citation: G. Catimel et al., PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY, Seminars in oncology, 23(1), 1996, pp. 24-27
A PHASE-II TRIAL OF DOCETAXEL IN PATIENTS (PTS) WITH ANTHRACYCLINE-RESISTANT (AR) METASTATIC BREAST-CANCER (MBC)
Authors: GUASTALLA JP BONNETERRE J FUMOLEAU P PICCART M TUBIANA M CHEVALLIER B NIEAMANN C ALAKL M NICHOL A RIVA A MARTY M
Citation: Jp. Guastalla et al., A PHASE-II TRIAL OF DOCETAXEL IN PATIENTS (PTS) WITH ANTHRACYCLINE-RESISTANT (AR) METASTATIC BREAST-CANCER (MBC), European journal of cancer, 31A, 1995, pp. 348-348
CONTINUOUS IV INFUSION OF VINORELBINE (VNB) AND BOLUS CISPLATINUM (CDDP) (CIVIC REGIMEN) AN EFFICIENT REGIMEN IN HORMONO RESISTANT METASTATIC BREAST-CANCER (MBC), AFTER FAILURE OF ANTRACYCLINE AND OR PACLITAXEL/
Authors: RAYCOQUARD I BLAY JY BACHELOT T BERTON D GUASTALLA JP CATIMEL G PHILIP T REBATTU P DROZ JP BIRON P
Citation: I. Raycoquard et al., CONTINUOUS IV INFUSION OF VINORELBINE (VNB) AND BOLUS CISPLATINUM (CDDP) (CIVIC REGIMEN) AN EFFICIENT REGIMEN IN HORMONO RESISTANT METASTATIC BREAST-CANCER (MBC), AFTER FAILURE OF ANTRACYCLINE AND OR PACLITAXEL/, European journal of cancer, 31A, 1995, pp. 353-353
A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC)
Authors: LHOMME C GUASTALLA JP DAUPLAT J FERRERO JM OBERLING F VENNIN P POUILLART P FUMOLEAU P KERBRAT P TUBIANA N HERON JF BUGAT R BACHELOT T SCHREINEROVA M FLEURY J NAMER M DUFOUR P DIERAS V SOLARMICHEL P PRUVOT I CHANEZ MA GARET F CHAZARD M PELLAECOSSET B
Citation: C. Lhomme et al., A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC), European journal of cancer, 31A, 1995, pp. 507-507
PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTEREDDAILY FOR 3 CONSECUTIVE DAYS EVERY 3 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: CATIMEL G CHABOT GG GUASTALLA JP DUMORTIER A COTE C ENGEL C GOUYETTE A MATHIEUBOUE A MAHJOUBI M CLAVEL M
Citation: G. Catimel et al., PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTEREDDAILY FOR 3 CONSECUTIVE DAYS EVERY 3 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMORS, Annals of oncology, 6(2), 1995, pp. 133-140
WHAT IS THE APPROPRIATE FOLLOW-UP FOR BRE AST-CANCER PATIENTS
Authors: GUASTALLA JP KERBRAT P
Citation: Jp. Guastalla et P. Kerbrat, WHAT IS THE APPROPRIATE FOLLOW-UP FOR BRE AST-CANCER PATIENTS, La Presse medicale, 24(31), 1995, pp. 1415-1417
Risultati: 1-25 | 26-32